Melanotan II – 10mg

Melanotan II (MT-2) is a synthetic cyclic heptapeptide analogue of alpha melanocyte stimulating hormone (α-MSH) with broad melanocortin receptor activity spanning MC1R, MC3R, MC4R, and MC5R subtypes. Hudson Science’s 10mg lyophilized vial delivers a higher concentration standalone presentation than the Hudson Science 10mg nasal spray, with the lyophilized injectable vial format serving distinct research purposes from the intranasal delivery system while providing double the compound availability per unit compared to CSD’s 5mg nasal spray presentation.

The 10mg lyophilized vial and nasal spray formats serve complementary research purposes within CSD’s Melanotan II range. The nasal spray’s intranasal delivery provides proximity to the olfactory epithelium and potential direct CNS access. Pharmacokinetically relevant for Melanotan II’s MC3R and MC4R hypothalamic targets where central nervous system receptor engagement is the primary research variable. The lyophilized vial’s reconstitute format supports subcutaneous parenteral administration research. The most extensively documented administration route in Melanotan II clinical literature alongside in vitro melanocortin receptor binding studies and comparative bioavailability research between intranasal and parenteral delivery routes at matched or varied concentration points.

Melanotan II’s broad multi receptor activity profile across MC1R, MC3R, MC4R, and MC5R produces a correspondingly diverse research scope. MC1R activation drives melanogenesis, eumelanin production in melanocyte cells generating the pigmentation biology and photoprotection research applications that represent Melanotan II’s most extensively documented area. MC3R and MC4R activation produces appetite regulation, energy homeostasis, and sexual function pathway research applications through hypothalamic melanocortin signaling. MC5R activation has generated emerging research interest in exocrine gland function and sebaceous secretion regulation. A fourth distinct receptor pathway that distinguishes Melanotan II’s research profile from PT-141, which has significantly reduced MC1R and MC5R activity compared to its Melanotan II parent compound.

Hudson Science formulations are stocked by Canada Steroid Depot following the same rigorous third party lab verification process applied to every product in our range. Each batch is tested for concentration accuracy and purity before being made available, with COA documentation available on request. CSD stocks Melanotan II across two formats: this 10mg lyophilized vial and the 10mg nasal spray, alongside PT-141 in matched nasal spray format, giving researchers complete melanocortin receptor agonist delivery route and comparative compound flexibility from a single verified Canadian supplier. All orders ship discreetly across Canada in plain, unmarked packaging with no identifying information on the exterior.

Reconstitute with bacteriostatic water prior to use. Store lyophilized peptide at 2–8°C away from direct light. Once reconstituted refrigerate and use within 28 days. Intended for research purposes only.

Commonly researched alongside PT-141 in comparative melanocortin receptor selectivity and central nervous system signaling studies. Browse CSD’s full peptide range for complete sourcing.